Jaguar Health Investor Relations Material
Latest events
Q4 2023
Jaguar Health
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Jaguar Health Inc
Access all reports
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company has a lead product candidate Mytesi, which is commercialized in the United States for the prevention of hemorrhagic cystitis in patients with cancer receiving certain types of chemotherapy; for the treatment of Noninfectious Diarrhea in adult patients living with HIV/AIDS receiving antiretroviral therapy; and for reduction of severity, frequency and duration of diarrhea.
Key slides for Jaguar Health Inc
Corporate Presentation
Jaguar Health Inc
Corporate Presentation
Jaguar Health Inc
Latest articles
Four Decades of IPOs: An Overview
An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.
24 Apr 2024
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Ticker symbol
Country
🇺🇸 United States